Glycopyrronium bromide (Seebri® Breezhaler®) 44 micrograms inhalation powder as hard capsules
All Wales Medicines Strategy Group (AWMSG)
Record ID 32013000419
English
Authors' recommendations:
Glycopyrronium bromide (Seebri® Breezhaler®) is recommended as an option for use within NHS Wales as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.wales.nhs.uk/sites3/Documents/371/glycopyrronium%20bromide%20%28Seebri%20Breezhaler%29%201455%20FAR.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Wales, United Kingdom
MeSH Terms
- Glycopyrrolate
- Administration, Inhalation
- Bronchodilator Agents
- Muscarinic Antagonists
Contact
Organisation Name:
All Wales Medicines Strategy Group
Contact Address:
All Wales Therapeutics and Toxicology Centre, Academic Centre, University Hospital Llandough, Penlan Road, Penarth, Vale of Glamorgan CF64 2XX
Contact Name:
AWTTC@wales.nhs.uk
Contact Email:
AWTTC@wales.nhs.uk
Copyright:
AWTTC
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.